Consumerization

The smartwatch is built for extreme environments and includes heart rate, sleep, blood oxygen and stress monitoring.

CEO of Lirio, Marten den Haring, explains how the company uses its proprietary Large Behavior Model to understand a person’s health behaviors, motivations and decision-making patterns to drive personalized patient engagement in healthcare.

The tech giant's SensorLM analyzes data from wearables to provide personalized insights into how everyday life affects one's body.

The FDA claims the wearable tech company's BPI offering is "adulterated" and "misbranded," and is being sold without the proper regulatory approvals.

The sale drew mixed reactions, with some U.S. states supporting it as a privacy measure and others objecting over legal and data concerns.

Dr. Ricky Bloomfield, Oura's first CMO, spoke with MobiHealthNews about his plans for the company and his vision to personalize Oura's offerings using generative AI.

The company has secured 510(k) clearance for its Apple Watch-powered seizure monitoring platform, expanding the role of wearables in epilepsy care.

The company touts that it recently surpassed 2.5 million rings sold and has seen its member base and revenue more than double over the past year.

The company says 510(k) clearance will allow it to pursue multiple business opportunities pertaining to remote patient monitoring and clinical trials.

The investment brings Oura's valuation to more than $5 billion. The partnership enables a two-way data flow between the Oura Ring and Dexcom's continuous glucose monitor.